ORIGINAL RESEARCH
Published on 20 Oct 2025
Cost-effectiveness of iruplinalkib versus crizotinib in first-line anaplastic lymphoma kinase-positive advanced non-small-cell lung cancer patients in China
doi 10.3389/fphar.2025.1651463
- 327 views
784
Total downloads
5,452
Total views and downloads
ORIGINAL RESEARCH
Published on 20 Oct 2025
SYSTEMATIC REVIEW
Published on 25 Jul 2025
OPINION
Published on 03 Jul 2025
ORIGINAL RESEARCH
Published on 02 Jun 2025